Abstract
Secreted phospholipases A2 (sPLA2s) modulate neuronal survival and neurotransmitter release. Here we show that sPLA2 (group III) synergistically increases glutamate-induced cell death and intracellular calcium ([Ca2+]i) in cultured primary cortical and hippocampal neurons. Whereas 1 microM glutamate elicited transient [Ca2+]i increases in all neurons that recovered 66% to baseline, 25 ng/ml sPLA2 pretreatment resulted in sustained [Ca2+]i increases, with only 5% recovery. At 250 nM glutamate, 25% of neurons failed to respond, and the average recovery time was 101 +/- 12 sec; sPLA2 increased recovery time to 158 +/- 6 sec, and only 2% of cells failed to respond. Both the noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 and the calcium-channel blocker cobalt inhibited this effect. Experiments with the glutamate uptake inhibitor L-trans-pyrollidine-2,4-dicarboxylic acid (2.5 microM) indicated that glutamate uptake sites are not a likely modulation point by sPLA2, whereas arachidonic acid (AA) potentiated calcium responses to glutamate. Thus the enhancement of glutamate-induced [Ca2+]i increases by sPLA2 may be due to modulation at NMDA receptors and/or calcium channels by AA. These results indicate that sPLA2 affects neuronal responses to both nontoxic (0.1-10 microM) and toxic (=25 microM) concentrations of glutamate, implicating this enzyme in neuronal functions in pathology.
Publication types
-
Research Support, U.S. Gov't, Non-P.H.S.
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Antimutagenic Agents / pharmacology
-
Arachidonic Acid / pharmacology
-
Calcium / metabolism*
-
Calcium Channels / drug effects
-
Calcium Channels / metabolism
-
Calcium Signaling / drug effects
-
Calcium Signaling / physiology*
-
Cell Death / drug effects
-
Cell Death / physiology*
-
Cells, Cultured
-
Cerebral Cortex / drug effects
-
Cerebral Cortex / metabolism
-
Cobalt / pharmacology
-
Dicarboxylic Acids / pharmacology
-
Dose-Response Relationship, Drug
-
Excitatory Amino Acid Antagonists / pharmacology
-
Glutamic Acid / metabolism*
-
Glutamic Acid / pharmacology
-
Hippocampus / drug effects
-
Hippocampus / metabolism
-
Intracellular Fluid / drug effects
-
Intracellular Fluid / metabolism
-
Neurons / drug effects
-
Neurons / enzymology*
-
Neurotransmitter Uptake Inhibitors / pharmacology
-
Phospholipases A / metabolism*
-
Phospholipases A / pharmacology
-
Phospholipases A2
-
Pyrrolidines / pharmacology
-
Rats
-
Receptors, N-Methyl-D-Aspartate / drug effects
-
Receptors, N-Methyl-D-Aspartate / metabolism*
-
Signal Transduction / drug effects
-
Signal Transduction / physiology
Substances
-
Antimutagenic Agents
-
Calcium Channels
-
Dicarboxylic Acids
-
Excitatory Amino Acid Antagonists
-
Neurotransmitter Uptake Inhibitors
-
Pyrrolidines
-
Receptors, N-Methyl-D-Aspartate
-
Arachidonic Acid
-
Cobalt
-
Glutamic Acid
-
pyrrolidine-2,4-dicarboxylic acid
-
Phospholipases A
-
Phospholipases A2
-
cobaltous chloride
-
Calcium